Gain-of-function mutations in GFAP lead to Alexander disease (AxD), which is characterized by a severe reactive astrocyte phenotype, including hypertrophic GFAP+ processes and astrocytic cytoplasmic inclusions of GFAP called Rosenthal fibers (Sosunov et al., 2018). The gene discussed is GFAP; the disease is Alexander disease.